DY131 - CAS 95167-41-2
Category: Inhibitor
Not Intended for Therapeutic Use. For research use only.
Molecular Formula:
C18H21N3O2
Molecular Weight:
311.38
COA:
Inquire
Targets:
Estrogen Receptor/ERR
Description:
DY131 is a novel selective agonist of ERRβ and ERRγ, which displays minimal activity at ERRα, ERα and ERβ at concentrations up to 30 μM. It could potentiate the ERRγ-induced growth inhibition in DU145- ERRγ and LNCaP- ERRγ prostate cancer cells in a dose-dependent manner. It inhibited the growth of the ERα-positive endometrial cancer cells but promoted that of the ERα-negative cancer cells. It had no effect on the structurally related receptors ERRα or the estrogen receptors alpha and beta (ERalpha/beta). It appears to inhibit Smo signaling through a common binding site shared by previously reported Smo agonists and antagonists. It has been demonstrated an antiproliferative/tumor-suppressing function for ERRγ in prostate cancer.
Publictions citing BOC Sciences Products
  • >> More
Purity:
>99 %
Appearance:
Yellow solid
Synonyms:
N-[(E)-[4-(diethylamino)phenyl]methylideneamino]-4-hydroxybenzamide;GSK4716;GW4716;GW574716;GSK 9089;DY-131
Solubility:
DMSO: ≥14 mg/mL
Storage:
2-8ºC
MSDS:
Inquire
Application:
DY131 has been demonstrated an antiproliferative/tumor-suppressing function for ERRγ in prostate cancer.
Quality Standard:
In-house standard
Shelf Life:
2 month in rt, long time
Quantity:
Grams to Kilograms
Melting Point:
234-236 °C
Density:
1.11±0.1 g/cm3 | Condition: Temp: 20 °C Press: 760 Torr
InChIKey:
WLKOCYWYAWBGKY-CPNJWEJPSA-N
InChI:
InChI=1S/C18H21N3O2/c1-3-21(4-2)16-9-5-14(6-10-16)13-19-20-18(23)15-7-11-17(22)12-8-15/h5-13,22H,3-4H2,1-2H3,(H,20,23)/b19-13+
Canonical SMILES:
CCN(CC)C1=CC=C(C=C1)C=NNC(=O)C2=CC=C(C=C2)O
Molecular Weight Calculator Molarity Calculator Solution Dilution Calculator

Related Estrogen Receptor/ERR Products


SNG-1153
(CAS: 1446712-19-1)

SNG-1153, derived from icaritin which is purified from Epimedium Genus, modulates ER-α36 and induces β-catenin phosphorylation and then down-regulates β-catenin...

CAS 343248-86-2 ERA63

ERA63
(CAS: 343248-86-2)

A selective agonist of estrogen receptor α

CAS 77599-17-8 Panomifene

Panomifene
(CAS: 77599-17-8)

Panomifene is an Estrogen receptor antagonist under the development of Egis Pharmaceuticals. Phase II clinical trials for the treatment of breast cancer was dis...

AZD9496
(CAS: 1639042-08-2)

AZD9496 is a potent and orally bioavailable selective estrogen receptor downregulator and antagonist. AZD9496 can induce ERα degradation in breast cancer cell l...

CAS 88431-47-4 Clomoxir

Clomoxir
(CAS: 88431-47-4)

Clomoxir is a carnitine O-palmitoyltransferase inhibitor.

GDC-0927

GDC-0927 (SRN-927) is a selective oral estrogen receptor degrader (SERD) in a phase I clinical trial for the treatment of postmenopausal women with locally adva...

Endoxifen E-isomer hydrochloride
(CAS: 1197194-61-8)

The hydrochloride salt form of E-isomer of Endoxifen which is a significant metamolite of Tamoxifen, could be a regulator of estrogen receptor and could be effe...

BHPI
(CAS: 56632-39-4)

BHPI is an antagonist of estrogen receptor α (ERα), for it elicits sustained ERα-dependent activation of the endoplasmic reticulum (EnR) stress sensor.

CAS 152-43-2 Quinestriol

Quinestriol
(CAS: 152-43-2)

Quinestriol, also called as Estrovis, is an orally active, long-acting, synthetic estrogen that is effective in hormone replacement therapy.

CAS 53-16-7 Estrone

Estrone
(CAS: 53-16-7)

Estrone is one of the three naturally occurring estrogens, the others being estradiol and estriol. Estrone is synthesized from androstenedione by the aromatase ...

CAS 182133-25-1 Arzoxifene

Arzoxifene
(CAS: 182133-25-1)

Arzoxifene, also known as LY353381, a synthetic aromatic derivative with anti-estrogenic properties, displays greater bioavailability and higher anti-estrogenic...

CAS 722533-56-4 Elacestrant

Elacestrant
(CAS: 722533-56-4)

Elacestrant, also referred to RAD1901, is a selective and orally available estrogen receptor (ERR) degrader (IC50= 48 and 870 nM for ERα and ERβ, respectively) ...

CAS 151555-47-4 RU 58668

RU 58668
(CAS: 151555-47-4)

RU 58668 is a pure antiestrogen that downregulates estrogen receptor expression (IC50 = 0.04 nM). It has been shown to display potent antiproliferative activity...

CAS 263717-53-9 PPT

PPT
(CAS: 263717-53-9)

PPT, also known as Propyl pyrazole triol, is an ERα selective agonist with a 410-fold relative binding affinity for ERα (49%) versus ERβ (0.12%) and therefore a...

Elacestrant S enantiomer

Elacestrant S enantiomer is an low activity enantiomer of Elacestrant. Elacestrant, also known as RAD1901, is a selective and orally<br/>bioavailable small-mole...

CAS 57-63-6 Ethinyl Estradiol

Ethinyl Estradiol
(CAS: 57-63-6)

Ethinyl Estradiol is a derivative of 17β-estradiol (E2), the major endogenous estrogen in humans. EE2 is an orally bioactive estrogen used in many formulations ...

CAS 313-06-4 Estradiol Cypionate

Estradiol Cypionate
(CAS: 313-06-4)

Estradiol cypionate is the 17 β-cyclopentylpropinate ester of estradiol, which inhibits ET-1 synthesis via estrogen receptor.

CAS 486-66-8 Daidzein

Daidzein
(CAS: 486-66-8)

Daidzein belongs to the group of isoflavones.Daidzein can be converted to its end metabolite S-equol in some humans based on the presence of certain intestinal ...

AZD9496 maleate
(CAS: 1639042-28-6)

AZD9496 maleate is potent downregulator of estrogen receptor in breast carcinoma cells and also antagonise ERα with good oral pharmacokinetic properties. It is ...

Elacestrant S enantiomer dihydrochloride

Elacestrant S enantiomer dihydrochloride is an low activity enantiomer of elacestrant dihydrochloride. Elacestrant, also referred to RAD1901, is a selective and...

Chemical Structure

CAS 95167-41-2 DY131

Quick Inquiry

Verification code

Featured Items